{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:34:29Z","timestamp":1791941669985,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.hoc.2017.09.005","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T19:34:13Z","timestamp":1510947253000},"page":"53-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Diagnosis of Castleman Disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Rapha\u00ebl","family":"Szalat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hoc.2017.09.005_bib1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymph node hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.hoc.2017.09.005_bib2","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1200\/JCO.2010.34.1909","article-title":"Clinical features and outcome in HIV-associated multicentric Castleman's disease","volume":"29","author":"Bower","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.005_bib3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/cid\/cis1009","article-title":"Human herpesvirus 8-related Castleman disease in the absence of HIV infection","volume":"56","author":"Dossier","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.hoc.2017.09.005_bib4","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2016-11-748855","article-title":"Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease","volume":"129","author":"Yu","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2017.09.005_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","article-title":"Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations","volume":"29","author":"Keller","year":"1972","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2017.09.005_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/SLA.0b013e318249dcdc","article-title":"Surgery in Castleman's disease: a systematic review of 404 published cases","volume":"255","author":"Talat","year":"2012","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.hoc.2017.09.005_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002030-199601000-00009","article-title":"Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients","volume":"10","author":"Oksenhendler","year":"1996","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.005_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/bjh.13378","article-title":"Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor","volume":"169","author":"Dong","year":"2015","journal-title":"Br J Haematol"},{"issue":"1049","key":"10.1016\/j.hoc.2017.09.005_bib9","doi-asserted-by":"crossref","first-page":"20140670","DOI":"10.1259\/bjr.20140670","article-title":"Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients","volume":"88","author":"Hill","year":"2015","journal-title":"Br J Radiol"},{"issue":"7","key":"10.1016\/j.hoc.2017.09.005_bib10","first-page":"486","article-title":"Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy","volume":"8","author":"van Rhee","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2017.09.005_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2017.09.005_bib12","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2017.09.005_bib13","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood-2011-08-376012","article-title":"Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease","volume":"119","author":"Gerard","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2017.09.005_bib14","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2017.09.005_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2003.09.020","article-title":"Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations","volume":"40","author":"Kaplan","year":"2004","journal-title":"Oral Oncol"},{"issue":"25","key":"10.1016\/j.hoc.2017.09.005_bib16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.hoc.2017.09.005_bib17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajh.24802","article-title":"POEMS syndrome: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri","year":"2017","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2017.09.005_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajh.23374","article-title":"Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients","volume":"88","author":"Royer","year":"2013","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.hoc.2017.09.005_bib19","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood.V99.8.3057","article-title":"High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome","volume":"99","author":"Jaccard","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2017.09.005_bib20","first-page":"320","article-title":"[Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly","volume":"51","author":"Takai","year":"2010","journal-title":"Rinsho Ketsueki"},{"issue":"2","key":"10.1016\/j.hoc.2017.09.005_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2017.09.005_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2249.2008.03786.x","article-title":"The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease","volume":"154","author":"Stebbing","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"5215","key":"10.1016\/j.hoc.2017.09.005_bib23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.hoc.2017.09.005_bib24","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","article-title":"How I treat autoimmune lymphoproliferative syndrome","volume":"118","author":"Rao","year":"2011","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.hoc.2017.09.005_bib25","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1212\/WNL.0000000000003405","article-title":"Clinical spectrum of Castleman disease-associated neuropathy","volume":"87","author":"Naddaf","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.hoc.2017.09.005_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/bjh.14152","article-title":"Autoimmune thrombotic thrombocytopenic purpura associated with HHV8-related multicentric Castleman disease","volume":"178","author":"London","year":"2017","journal-title":"Br J Haematol"},{"issue":"Suppl 3","key":"10.1016\/j.hoc.2017.09.005_bib27","doi-asserted-by":"crossref","first-page":"iii119","DOI":"10.1093\/ndt\/gfr245","article-title":"Renal involvement in a large cohort of Chinese patients with Castleman disease","volume":"27","author":"Xu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.hoc.2017.09.005_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ndt\/gfq427","article-title":"Renal involvement in Castleman disease","volume":"26","author":"El Karoui","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.hoc.2017.09.005_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0344-0338(97)80015-5","article-title":"Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman' disease: a clinicopathologic study of five cases","volume":"193","author":"Kojima","year":"1997","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.hoc.2017.09.005_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2559.1991.tb00833.x","article-title":"Hodgkin's disease presenting with the histological features of Castleman's disease","volume":"18","author":"Maheswaran","year":"1991","journal-title":"Histopathology"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858817301454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858817301454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:06:01Z","timestamp":1760184361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858817301454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0889858817301454"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2017.09.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of Castleman Disease","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}